Clinical trial
Predicting Cancer Onset in Lynch Syndrome by Liquid Biopsies
NCT07360834 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Cancer Onset in Lynch Syndrome by Liquid Biopsies
- Lead sponsor
- UNICANCER
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- December 1, 2030
- Enrollment
- 2,000 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
lynch syndrome